loader
Please Wait
Applying Filters...

Seqens Seqens

X

Product List of all Active Pharmaceutical Ingredients (APIs) supplied/manufactured by Shandong Anxin Pharmaceutical

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Amikacin Sulfate (1)

02 Capecitabine (1)

03 Celecoxib (1)

04 Hydroxyurea (1)

05 Imatinib Mesylate (2)

06 Olmesartan Medoxomil (1)

07 Piperacillin Sodium (1)

08 Quetiapine Hemifumarate (1)

09 Tadalafil (1)

10 Tazobactam Sodium (1)

filter

01 Active (1)

02 Blank (10)

filter

01 Expired (1)

02 Valid (9)

03 Blank (1)

filter

01 Blank (11)

filter

01 Blank (11)

URL Supplier Web Content
See all info for this product

See Less

USDMF

Close USDMF

CEP/COS

Found CEP/COS

R1-CEP 2010-308 - Rev 01
Valid
Amikacin sulfate
2020-01-16
Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
Status
Valid
 
Filing Details
Amikacin sulfate
Issue/Submission Date
2020-01-16
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
See all info for this product

See Less

USDMF

Close USDMF

CEP/COS

Found CEP/COS

CEP 2014-189 - Rev 03
Valid
Capecitabine
2024-02-19
Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
Status
Valid
 
Filing Details
Capecitabine
Issue/Submission Date
2024-02-19
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
See all info for this product

See Less

USDMF

Close USDMF

CEP/COS

Found CEP/COS

R1-CEP 2015-297 - Rev 01
Valid
Celecoxib
2022-08-26
Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
Status
Valid
 
Filing Details
Celecoxib
Issue/Submission Date
2022-08-26
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
See all info for this product

See Less

USDMF

Close USDMF

CEP/COS

Found CEP/COS

R1-CEP 2005-051 - Rev 04
Valid
Hydroxycarbamide
2021-09-24
Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
Status
Valid
 
Filing Details
Hydroxycarbamide
Issue/Submission Date
2021-09-24
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
See all info for this product

See Less

USDMF

Close USDMF

CEP/COS

Found CEP/COS

R1-CEP 2016-039 - Rev 00
Valid
Imatinib mesilate
2022-06-01
Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
Status
Valid
 
Filing Details
Imatinib mesilate
Issue/Submission Date
2022-06-01
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
See all info for this product

See Less

USDMF

Close USDMF

CEP/COS

Found CEP/COS

R0-CEP 2017-292 - Rev 02
Valid
Imatinib mesilate, β form
2022-06-27
Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
Status
Valid
 
Filing Details
Imatinib mesilate, β form
Issue/Submission Date
2022-06-27
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
See all info for this product

See Less

USDMF

Close USDMF

CEP/COS

Found CEP/COS

R1-CEP 2014-225 - Rev 00
Valid
Olmesartan medoxomil
2022-01-05
Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
Status
Valid
 
Filing Details
Olmesartan medoxomil
Issue/Submission Date
2022-01-05
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
See all info for this product

See Less

USDMF

Close USDMF

CEP/COS

Found CEP/COS

R1-CEP 2015-389 - Rev 00
Valid
Piperacillin monohydrate
2022-04-22
Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
Status
Valid
 
Filing Details
Piperacillin monohydrate
Issue/Submission Date
2022-04-22
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
See all info for this product

See Less

USDMF

Close USDMF

CEP/COS

Found CEP/COS

R1-CEP 2016-001 - Rev 00
Valid
Tadalafil
2022-02-02
Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
Status
Valid
 
Filing Details
Tadalafil
Issue/Submission Date
2022-02-02
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
See all info for this product

See Less

USDMF

Found USDMF

36268
Active
TAZOBACTAM (TRIAZOLE PROCESS)
2022-05-23
CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
36268
Status
Active
Fees Unpaid
Reviewed
 
Filing Details
TAZOBACTAM (TRIAZOLE PROCESS)
Issue/Submission Date
2022-05-23
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY